In a clinical study using biopsy samples from 101 patients with melanoma lymph node metastases, we demonstrated that high PROM2 expression was associated with a risk of distant lung and brain metastasis and shorter survival.4 The gene discussed is PROM2; the disease is metastatic malignant neoplasm in the lymph nodes.